A New <i>In Silico</i> Comparison of the Relative Affinity of Enantiomeric Chloroquine (CQ) and Hydroxychloroquine (HCQ) for ACE2

A New <i>In Silico</i> Comparison of the Relative Affinity of Enantiomeric Chloroquine (CQ) and Hydroxychloroquine (HCQ) for ACE2

<b>Background/Objectives</b>: Chloroquine (CQ) and hydroxychloroquine (HCQ) have been the subject of debate in the treatment of COVID-19 due to the lack of conclusive evidence regarding their efficacy and safety. Our study aims to investigate the molecular interaction between the enantio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Carlos Naranjo-Castañeda, Marco A. García-Revilla, Eusebio Juaristi
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Pharmaceuticals
Subjects:	COVID-19 ACE2 chloroquine hydroxychloroquine enantiodifferentiation molecular docking
Online Access:	https://www.mdpi.com/1424-8247/18/7/982
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CHLOROQUINE AND HYDROXYCHLOROQUINE ARE AVAILABLE TREATMENT OPTIONS TO FIGHT WITH COVID-19
by: Shadia S. Alhamd, et al.
Published: (2020-11-01)

Usefulness of Hydroxychloroquine and Chloroquine in the Prevention of Malaria in Systemic Lupus Erythematosus: Experience from the University of Nigeria Teaching Hospital Enugu, Nigeria
by: Celestine C. Okwara, et al.
Published: (2025-07-01)

Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs
by: O. V. Gaisenok
Published: (2020-07-01)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
by: Xiaoxuan Sun, et al.
Published: (2020-01-01)

Corneal Ulcer Following Prolonged Topical Chloroquine Phosphate
by: Samarth Mishra, et al.
Published: (2018-04-01)

A randomized controlled trial on the effect of hydroxychloroquine in mild Graves’ orbitopathy (GO-HCQ): study protocol
by: Chia-Hung Lin, et al.
Published: (2025-08-01)

Pfcrt mutant haplotypes may not correspond with chloroquine resistance
by: Diganta Goswami, et al.
Published: (2014-06-01)

Hydroxychloroquine in rheumatic autoimmune disorders and beyond
by: Eliise Laura Nirk, et al.
Published: (2020-07-01)

Chloroquine mitigates long-term effects of in vitro culture in mouse embryos
by: Kaname Sato, et al.
Published: (2025-08-01)

Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01)

Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01)

Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax ?
by: Nicholas J. White, et al.
Published: (2025-05-01)

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)
by: Xiang Li, et al.
Published: (2025-06-01)

Research progress on ACE immobilization and immobilized ACE used for affinity separation and enrichment of food-derived antihypertensive peptides
by: ZHANG Jingjing, et al.
Published: (2024-10-01)

Chloroquine inhibits artificial oocyte activation induced by ethanol or Sr2+ but not by sperm in mice
by: Tadashi YAMAZAKI, et al.
Published: (2024-12-01)

Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01)

Multimodal imaging in a case of hydroxychloroquine induced maculopathy
by: Asma Khallouli, et al.
Published: (2025-07-01)

Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals
by: Bolajoko A. Aina, et al.
Published: (2008-02-01)

Harnessing chitosan for zinc and hydroxychloroquine delivery, interactions with fibronectin, and antibacterial activity
by: Anju Manuja, et al.
Published: (2025-03-01)

Mechanism of telomerase inhibitor BIBR1532 combined with autophagy inhibitor CQ in suppressing survival of melanoma cells
by: GONG Weihua, CHEN Lan, ZHAO Kun, KE Zhui, XU Qing, GUO Xianling
Published: (2025-05-01)

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01)

Prevalence of molecular markers of chloroquine resistance in malaria parasites in East Africa: A systematic review and meta-analysis
by: Wagaw Abebe, et al.
Published: (2025-03-01)

Hydroxychloroquine Induced Retinopathy: A Case Series
by: Maryam Mobini, et al.
Published: (2016-10-01)

The effect of chloroquine on cervical cancer via the PI3K/AKT/MDM2 pathway
by: Dandan Xu, et al.
Published: (2025-06-01)

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
by: Pankaj Bansal, et al.
Published: (2021-01-01)

Chloroquine Enhances Chemosensitivity of Breast Cancer via mTOR Inhibition
by: Zhihao Lin, et al.
Published: (2025-04-01)

Degradation of chloroquine phosphate by low-pressure ultraviolet/peroxyacetic acid: Performance, degradation pathway and mechanism studies
by: Chunxue Li, et al.
Published: (2025-09-01)

Long-term application of hydroxychloroquine could not prevent the infection of COVID-19
by: Yin Zhu, et al.
Published: (2020-12-01)

PREVALENCE AND RISK FACTORS ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON HYDROXYCHLOROQUINE: A POPULATION-BASED STUDY
by: Antoine BOUSTANY, et al.
Published: (2025-04-01)

The Assessment of the Effect of Autophagy Inhibitors—Chloroquine and 3-Methyladenine on the Antitumor Activity of Trametinib Against Amelanotic Melanoma Cells
by: Dominika Stencel, et al.
Published: (2025-04-01)

Metformin and chloroquine enhanced the efficacy of cytarabine in acute lymphoblastic leukemia cell lines: a drug repositioning approach
by: Ahmad Moradi Poodeh, et al.
Published: (2025-05-01)

How different is the status of depression and anxiety in patients with rheumatoid arthritis receiving methotrexate with sulfasalazine or hydroxychloroquine?
by: Mansour Babaei, et al.
Published: (2023-09-01)

Treatment of Subcutaneous Sarcoidosis with Hydroxychloroquine in a Hepatitis B Carrier Patient: A Case Report
by: Selma Erdoğan Düzcü, et al.
Published: (2025-04-01)

Combined disease modifying treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine
by: N A Sergiets, et al.
Published: (2009-02-01)

Pilot Trial of Hydroxychloroquine as Add-On Therapy in Patients With Membranous Nephropathy
by: Hongyu Yang, et al.
Published: (2024-12-01)

Efficacy of chloroquine with primaquine for uncomplicated Plasmodium vivax malaria without G6PD testing in Northwest Ethiopia: a one-arm in vivo prospective therapeutic efficacy study
by: Eyob Getu, et al.
Published: (2025-06-01)

Chloroquine induces eryptosis in P. falciparum-infected red blood cells and the release of extracellular vesicles with a unique protein profile
by: Claudia Carrera-Bravo, et al.
Published: (2025-05-01)

The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19
by: Yu. N. Belenkov, et al.
Published: (2020-12-01)

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
by: Mondher Toumi, et al.
Published: (2020-01-01)

Pharmacophore mapping of Angiotensin Converting Enzymes (ACEs): Insight to Binding Site of ACE1 and ACE2
by: Navista Sri Octa Ujiantari, et al.
Published: (2024-10-01)